Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas
Top Cited Papers
- 15 March 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (6) , 2162-2169
- https://doi.org/10.1158/0008-5472.can-04-3924
Abstract
Among the genes most commonly identified in gene expression profiles of epithelial ovarian carcinomas (EOC) is the gene for human epididymis protein 4 (HE4). To ascertain its clinical utility, we did a comprehensive assessment of HE4 protein expression in benign and malignant ovarian and nonovarian tissues by immunohistochemistry. In comparison with normal surface epithelium, which does not express HE4, we found that cortical inclusion cysts lined by metaplastic Mullerian epithelium abundantly express the protein. Its expression in tumors was restricted to certain histologic subtype: 93% of serous and 100% of endometrioid EOCs expressed HE4, whereas only 50% and 0% of clear cell carcinomas and mucinous tumors, respectively, were positive. Tissue microarrays revealed that the majority of nonovarian carcinomas do not express HE4, consistent with our observation that HE4 protein expression is highly restricted in normal tissue to the reproductive tracts and respiratory epithelium. HE4 is predicted to encode a secreted protein. Using reverse transcription-PCR, we identified ovarian cancer cell lines that endogenously overexpress HE4. Cultured medium from these cells revealed a secreted form of HE4 that is N-glycosylated. This observation is consistent with the recent report that HE4 circulates in the bloodstream of patients with EOC. Therefore, HE4 is a secreted glycoprotein that is overexpressed by serous and endometrioid EOCs. Its expression in cortical inclusion cysts suggests that formation of Mullerian epithelium is a prerequisite step in the development of some types of EOCs.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2Oncogene, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomiesCancer, 2003
- Gene Expression Patterns in Ovarian CarcinomasMolecular Biology of the Cell, 2003
- Status of Tumor Markers in Ovarian Cancer ScreeningJournal of Clinical Oncology, 2003
- Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1Oncogene, 2003
- A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic proteinBiochemical Journal, 2002
- The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene, 2002
- Establishment and Characterization of Human Ovarian Carcinoma Cell LinesGynecologic Oncology, 1997
- A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1Biology of Reproduction, 1991